Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis.
Vu T, Datta PK. · 2017
Read Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis. by Vu T, Datta PK. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5742819.txt.
Introduction
Vu and Datta review how colorectal cancer cells switch form and spread. The switch, called epithelial to mesenchymal transition, loosens cell contacts. Cells gain movement and reach distant sites more easily. The review gathers fresh work on what controls this switch.
Signals such as WNT and TGF-beta can turn the switch on. They act through factors like ZEB1 and ZEB2, which cut E-cadherin and raise other markers. Small RNAs in the miR-34 and miR-200 families hold the switch back. Tumor cells in the blood that show this switch may flag spread, the authors note.
Catalog record
| CREATOR | Vu T, Datta PK. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis By Trung Vu, Pran K Datta Published in: Cancers DOI: 10.3390/cancers9120171 ABSTRACT Abstract Epithelial to mesenchymal transition (EMT) is a process during which cells lose their epithelial characteristics, for instance cell polarity and cell–cell contact, and gain mesenchymal properties, such as increased motility. In colorectal cancer (CRC), EMT is associated with an invasive or metastatic phenotype. In this review, we discuss recent studies exploring novel regulation mechanisms of EMT in CRC, including the identification of new CRC EMT regulators. Upregulation of inducers can promote EMT, leading to increased invasiveness and metastasis in CRC. These inducers can downregulate E-cadherin and upregulate N-cadherin and vimentin (VIM) through modulating EMT-related signaling pathways, for instance WNT/β-catenin and TGF-β, and EMT transcription factors, such as zinc finger E-box binding homeobox 1 (ZEB1) and ZEB2. In addition, several microRNAs (miRNAs), including members of the miR-34 and miR-200 families, are found to target mRNAs of EMT-transcription factors, for example ZEB1, ZEB2, or SNAIL. Downregulation of these miRNAs is associated with distant metastasis and advanced stage tumors. Furthermore, the role of EMT in circulating tumor cells (CTCs) is also discussed. Mesenchymal markers on the surface of EMT CTCs were found to be associated with metastasis and could serve as potential biomarkers for metastasis. Altogether, these studies indicate that EMT is orchestrated by a complicated network, involving regulators of different signaling pathways. Further studies are required to understand the mechanisms underlying EMT in CRC. Keywords: EMT, colorectal cancer, metastasis 1. INTRODUCTION Colorectal cancer (CRC) remains the second leading cause of cancer death in the United States. More than 50% of CRC patients will develop liver metastases during their lifespan [1]. Despite the development of treatment regimens, there is no effective therapy for advanced CRC with metastasis. Although inherited genetic susceptibility has an important role in a subset of CRC cases, the vast majority of CRC cases are sporadic and non-inherited [2]. Sporadic pre-neoplastic lesions gradually accumulate genetic and epigenetic modifications that allow uncontrolled proliferation and cell survival, followed by invasive and metastatic properties typical of colorectal carcinoma [3]. Understanding the molecular mechanisms underlying these transitions, especially how colorectal cancer cells acquire invasive and metastatic properties, is important for the development of optimized strategies to treat CRC. Epithelial to mesenchymal transition (EMT) is a complicated cellular process, during which epithelial cells acquire a mesenchymal phenotype. EMT has been categorized into three types based on the physiological tissue context: (1) embryonic development and organ formation [4]; (2) wound healing and organ fibrosis [5]; and (3) cancer progression [6]. Type 3 EMT is associated with invasive or metastatic phenotype [7]. In the past decade, increasing numbers of studies have provided strong evidence for the vital role that EMT plays in cancer progression and metastasis in many types of malignancies including CRC [8]. During EMT, tumor cells undergo tight junction dissolution, disruption of apical–basal polarity, and reorganization of the cytoskeletal architecture, which enable cells to develop an invasive phenotype. In cancer cells, EMT is abnormally regulated by extracellular stimuli derived from the tumor microenvironment, including growth factors and inflammatory cytokines, along with intra-tumoral physical stresses such as hypoxia [9]. Therefore, EMT programming allows tumor cells to adapt to the constant changes of the human tumor microenvironment, and thus to successfully metastasize. In this review, we will describe current knowledge about the mechanisms and regulators of EMT in CRC. These regulators are aberrantly expressed in human CRC and their expression correlates with induction of EMT and cancer metastasis. We will also discuss the importance of studying the role of EMT in metastasis, and how EMT can be considered as an applicable target for therapeutic strategies, especially for patients with CRC metastasis. 2. REGULATION OF EMT IN COLORECTAL CANCER The process of EMT requires the cooperation, in a timely manner, of a complex network, consisting of molecular signaling pathways and regulators. These factors are categorized into three groups: the effector molecules which execute the EMT program (EMT effectors), the transcription factors which orchestrate the EMT program (EMT core regulators), and the extracellular cues which activate the EMT program (EMT inducers) [10]. 2.1. EMT Effectors A majority of EMT effectors are subcellular structure proteins that define the epithelial or mesenchymal phenotype of a cell. EMT is characterized by the downregulation of genes encoding for epithelial cell junction proteins (E-cadherin, claudins, and occludins) and the activation of genes, of which the protein products (vimentin, fibronectin and N-cadherin) promote mesenchymal adhesion. Among them, a key feature of EMT is the downregulation of E-cadherin, leading to the destabilization of adherens junctions. In response to a variety of induction signals, E-cadherin is subjected to various levels of regulation, including transcriptional repression [11], promoter methylation [12], and protein phosphorylation and degradation [13]. Loss of E-cadherin expression is associated with a poor prognosis in stage III CRC [14]. Additional key EMT effector molecules are proteins that promote cell migration and invasion during EMT. Fibronectin, an extracellular protein required for mesenchymal cell migration, is frequently induced upon EMT activation. High levels of fibronectin expression are associated with poor prognosis in CRC [15]. Furthermore, knockdown of fibronectin suppresses CRC cell proliferation via the NF-κB/p53-apoptosis signaling pathway and arrested cells in the S phase [16]. Overexpression of N-cadherin, another mesenchymal marker, is correlated with metastasis and worse survival of CRC patients [17]. 2.2. EMT Core Regulators-Transcription Factors Driving EMT The regulation of EMT requires robust transcriptional machinery, consisting largely of developmental transcription factors which regulate epithelial and mesenchymal markers in a coordinated manner. There are three major groups of EMT-activating transcription factors: the SNAIL family of zinc-finger transcription factors SNAIL/SLUG, the zinc finger E-box binding homeobox (ZEB) family of transcription factors ZEB1/ZEB2, and the TWIST family of basic helix-loop-helix (bHLH) transcription factors TWIST1/TWIST2. The expression of these three groups is activated early in EMT, and thus they have central roles in development and cancer. The roles of these transcription factors in EMT have been well established in a variety of cancers including colorectal cancer. In addition to the three major families of EMT transcription factors, other transcription factors were recently shown to induce EMT in colorectal cancer. One of them is Prospero Homeobox 1 (PROX1) which belongs to the family of homeobox transcription factors. Others are forkhead box (FOX) transcription factors, which are defined by a DNA-binding forkhead domain. These transcription factors contribute to EMT by functionally regulating target genes or controlling the expression of each other. The activities of these EMT transcription factors vary by tissue type and depend on regulatory signaling pathways. Aberrant regulation of EMT-related transcription factors and mesenchymal markers has been identified in CRC and is associated with increased rate of cancer recurrence and decreased survival of CRC patients (Table 1). Previous studies reported that overexpression of EMT-related transcription factors, such as SNAIL [18], SLUG [19], TWIST1 [20], TWIST2 [21], ZEB1 [22], ZEB2 [23] PROX1 [24], FOXC2 [25], FOXQ1 [26], FOXC1 [27], and FOXM1 [28] are associated with invasiveness, metastasis, and poor prognosis of CRC. [Table: Factors/proteins involved in EMT and their relevance to colorectal cancer.] 2.2.1. SNAIL Transcription Factors The SNAIL family of zinc-finger transcription factors, consisting of SNAIL1, SNAIL2, and SNAIL3 (also known as SNAIL, SLUG, and SMUC, respectively),